Managing patients with lung cancer. Guidelines must help bring us in line with European standards
O'Brien, M.E.; Cullen, M.
Bmj 320(7249): 1604-1605
2000
ISSN/ISBN: 0959-8138 PMID: 10896440 Document Number: 513412
Document emailed within 1 workday
Related Documents
O'Higgins, N.; Linos, D.A.; Blichert-Toft, M.; Cataliotti, L.; de Wolf, C.; Rochard, F.; Rutgers, E.J.; Roberts, P.J.; Mattheiem, W.; da Silva, M.A.; Holmberg, L.; Schulz, K.D.; Smola, M.G.; Mansel, R.E. 1998: European guidelines for quality assurance in the surgical management of mammographically detected lesions. European Breast Cancer Working Group Annales Chirurgiae et Gynaecologiae 87(1): 110-112Coindre, J.M.; Blanc-Vincent, M.P.; Collin, F.; Mac Grogan, G.; Balaton, A.; Voigt, J.J. 2003: 2001 Standards, Options and Recommendations: practice guidelines for difficult diagnoses in surgical pathology or cytopathology in cancer patients Annales de pathologie 23(5): 460-470
1989: Diagnosis and first-line treatment of patients with lung cancer in Italian general hospitals. G.I.V.I.O. (Interdisciplinary Group for Cancer Evaluation) Tumori 75(2): 163-167
Trakhtenberg, A.K.; Popov, M.I.; Zakharchenkov, A.V.; Kim, I.K. 1990: A method of managing the bronchial stump after surgical and combined treatment of patients with cancer of the lung Khirurgiia 4: 15-18
Hashizume, T.; Ogura, T.; Kozawa, S.; Kobayashi, N.; Tagawa, A.; Miyazawa, N.; Watanuki, Y.; Takahashi, H. 2006: Gefitinib as a first-line therapy in patients with advanced non-small cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 33(4): 467-470
Levy, B.P.; Rao, P.; Becker, D.J.; Becker, K. 2016: Attacking a Moving Target: Understanding Resistance and Managing Progression in EGFR-Positive Lung Cancer Patients Treated with Tyrosine Kinase Inhibitors Oncology 30(7): 601-612
Mencoboni, M.; Bergaglio, M.; Serra, M.; Ivaldi, G.P.; Tredici, S.; Racchi, O.; Rebella, L.; Galbusera, V.; Grosso, M.; Faravelli, B. 2007: Maintenance therapy with gefitinib after first-line chemotherapy in patients affected by advanced non-small cell lung cancer Anticancer Research 27(6c): 4425-4429
Abou-Mourad, Y.; Otrock, Z.K.; Makarem, J.A.; Kattan, J.G.; Farhat, F.S.; Jalloul, R.; Mokaddem, W.T.; Ghosen, M.G.; Taher, A.T.; Chehal, A.A.; Shamseddine, A.I. 2008: Docetaxel and irinotecan as first-line chemotherapy in patients with advanced non-small-cell lung cancer: a pilot study Le Journal Medical Libanais. Lebanese Medical Journal 56(1): 16-21
Pyörälä, K.; de Backer, G.; Graham, I.; Poole-Wilson, P.; Wood, D. 1995: Prevention of coronary disease in clinical practice. Guidelines of the working group of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension Archives des maladies du coeur et des vaisseaux 88(10 Suppl): 1493-1542
Goto, I.; Yoneda, S.; Yamamoto, M.; Kawajiri, K. 1996: Prognostic significance of germ line polymorphisms of the CYP1A1 and glutathione S-transferase genes in patients with non-small cell lung cancer Cancer Research 56(16): 3725-3730
Haire, B.G.; Folayan, M.Oluwatoyin.; Brown, B. 2014: Standards and guidelines for HIV prevention research: considerations for local context in the interpretation of global ethical standards African Journal of Reproductive Health 18(3 Spec No): 55-65
Smeets, F. 1990: European lung assistance a european network of travel assistance for copd patients American Review of Respiratory Disease 141(4 Part 2): A199
Brunelli, V.; Mulvihill, C.; Kerr, J.; Allan, H. 2018: P3.07-02 Expectations, Standards and Performance Framework to Support the Lung Cancer Support Nurse in Lung Foundation Australia Journal of Thoracic Oncology 13(10): S933-S934
Brunelli, V.; Mulvihill, C.; Kerr, J.; Allan, H. 2018: P3.07-02 Expectations, Standards and Performance Framework to Support the Lung Cancer Support Nurse in Lung Foundation Australia Journal of Thoracic Oncology 13(10): S933-S934
Van Zandwijk, N.; Dalesio, O. 1994: Platinum-based chemotherapy in non-small cell lung cancer: the experience of the European Organization for the Research and Treatment of Cancer Seminars in Oncology 21(3 Suppl 6: 66-71
Pepine, C.J.; Conti, C.R. 2004: Managing hypertension in European patients with coronary artery disease: design, results, and clinical implications of INVEST Italian Heart Journal: Official Journal of the Italian Federation of Cardiology 5(6): 411-416
Evans, W.K.; Will, B.P.; Berthelot, J.M.; Wolfson, M.C. 1995: The cost of managing lung cancer in Canada Oncology 9(11 Suppl): 147-153
O'Dwyer, C.; Hade, D.; Fan, C.W.; Cunningham, C.; Kenny, R.A. 2010: How well are European Society of Cardiology (ESC) guidelines adhered to in patients with syncope? Irish Medical Journal 103(1): 11-14
Sáez Fernández, A.; Sistac Ballarín, J.M.; Martínez Torrente, F.; Calvo Vecino, J.M.; Olmos Rodríguez, M. 2011: Reflections on residency training under the current recommendations of the European Union of Medical specialists and the European Board of Anaesthesia (UEMS/EBA guidelines) Revista espanola de anestesiologia y reanimacion 58(7): 444-450
Langfort, R.; Szołkowska, Młgorzata. 2012: Recommendation concerning the microscopic classification of lung adenocarcinoma presented by International Association for the Study of Lung Cancer, American Thoracic Society, and European Respiratory Society Pneumonologia i alergologia polska 80(2): 99-100